biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by fishtailon Jan 19, 2021 10:34am

166 Views

Post# 32325784

chomp, chomp, chomp...

Recent Trades - Last 10 of 102

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
10:17:26	U	0.67	0.12	1,000	33 Canaccord	1 Anonymous	K
10:17:21	H	0.67	0.12	1,000	1 Anonymous	1 Anonymous	K
10:17:21	V	0.67	0.12	1,500	1 Anonymous	1 Anonymous	K
10:17:19	A	0.67	0.12	3,000	7 TD Sec	33 Canaccord	K
10:17:19	H	0.67	0.12	500	7 TD Sec	1 Anonymous	K
10:17:19	V	0.67	0.12	8,500	7 TD Sec	1 Anonymous	K
10:13:41	M	0.63	0.08	110	7 TD Sec	89 Raymond James
10:13:41	O	0.63	0.08	1,500	1 Anonymous	89 Raymond James	K
10:13:10	A	0.68	0.13	3,500	9 BMO Nesbitt	33 Canaccord	K
10:13:10	V	0.68	0.13	2,000	9 BMO Nesbitt	85 Scotia	K